Latest Naloxone Stories
LONDON, Oct. 2, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.
JOHNSTOWN, Pa., Sept.
ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g.
Big Cities Health Coalition Urges Immediate Federal Action WASHINGTON, Sept.
September 4th ceremony celebrates 2014 accomplishments including FDA approval and anticipated commercial launch of BUNAVAIL RALEIGH, N.C., Sept.
Harbor Village Florida Comments on New Street Drug Showing to be Much More Powerful Than Heroin USA (PRWEB) August 31, 2014 According to an article posted
RALEIGH, N.C., Aug. 27, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) approved by FDA for the maintenance treatment of opioid dependence; US launch planned for late Q3 RALEIGH, N.C., Aug.
Mental Health Center at the Cedars-Sinai Medical Towers becomes the first medical practice in Los Angeles to distribute free prescription Naloxone to local treatment centers and sober living facilities.
LONDON, July 30, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.